Genomic landscape of platinum resistant and sensitive testicular cancers.
View/ Open
Date
2020-05-04ICR Author
Author
Loveday, C
Litchfield, K
Proszek, PZ
Cornish, AJ
Santo, F
Levy, M
Macintyre, G
Holryod, A
Broderick, P
Dudakia, D
Benton, B
Bakir, MA
Hiley, C
Grist, E
Swanton, C
Huddart, R
Powles, T
Chowdhury, S
Shipley, J
O'Connor, S
Brenton, JD
Reid, A
de Castro, DG
Houlston, RS
Turnbull, C
Type
Journal Article
Metadata
Show full item recordAbstract
While most testicular germ cell tumours (TGCTs) exhibit exquisite sensitivity to platinum chemotherapy, ~10% are platinum resistant. To gain insight into the underlying mechanisms, we undertake whole exome sequencing and copy number analysis in 40 tumours from 26 cases with platinum-resistant TGCT, and combine this with published genomic data on an additional 624 TGCTs. We integrate analyses for driver mutations, mutational burden, global, arm-level and focal copy number (CN) events, and SNV and CN signatures. Albeit preliminary and observational in nature, these analyses provide support for a possible mechanistic link between early driver mutations in RAS and KIT and the widespread copy number events by which TGCT is characterised.
Collections
Subject
Humans
Neoplasms, Germ Cell and Embryonal
Testicular Neoplasms
Genetic Predisposition to Disease
Platinum
Organoplatinum Compounds
ras Proteins
Genomics
Signal Transduction
Drug Resistance, Neoplasm
Mutation
Male
Proto-Oncogene Proteins c-kit
DNA Copy Number Variations
Whole Exome Sequencing
Research team
Cancer Genomics
Sarcoma Molecular Pathology
Clinical Academic Radiotherapy (Huddart)
Language
eng
Date accepted
2020-03-23
License start date
2020-05-04
Citation
Nature communications, 2020, 11 (1), pp. 2189 - ?
Publisher
NATURE PUBLISHING GROUP